Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 10,775 | 8,875 | 32,644 | 1,834 | 1,718 |
| Cost of Goods | 4,355 | 5,381 | 4,139 | N/A | N/A |
| Gross Profit | 6,421 | 3,494 | 28,505 | 1,834 | 1,718 |
| Operating Expenses | 59,800 | 38,133 | 36,577 | 28,007 | 29,280 |
| Operating Income | -53,025 | -34,259 | -7,933 | -26,173 | -27,562 |
| Interest Expense | 2,687 | 2,169 | 1,185 | 1,513 | -557 |
| Other Income | -1,685 | 639 | 322 | 1,034 | -1,914 |
| Pre-tax Income | -57,398 | -35,789 | -8,796 | -26,652 | -28,919 |
| Income Tax | 1,327 | 98 | -203 | -138 | -174 |
| Net Income Continuous | -58,725 | -35,886 | -8,593 | -26,515 | -28,745 |
| Net Income | $-58,725 | $-35,886 | $-8,593 | $-26,515 | $-28,745 |
| EPS Basic Total Ops | -1.51 | -0.90 | -0.23 | -0.74 | -0.74 |
| EPS Basic Continuous Ops | -1.51 | -0.90 | -0.23 | -0.74 | -0.74 |
| EPS Diluted Total Ops | -1.51 | -0.90 | -0.23 | -0.74 | -0.74 |
| EPS Diluted Continuous Ops | -1.51 | -0.90 | -0.23 | -0.74 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -1.56 | -0.90 | N/A | N/A | N/A |
| EBITDA(a) | $-53,025 | $-31,155 | $-7,933 | $-26,173 | $-27,562 |